InsiderClue
Stocks · Health care · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Cencora

COR Clue Score59
United States Fiscal year ends September CIK 0001140859 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Lazarus Krikorian
2 Nov 2026
SVP & Chief Accounting Officer
Sold on a plan
986
$330.96
$326.33K
Lazarus Krikorian
1 Oct 2026
SVP & Chief Accounting Officer
Sold on a plan
986
$303.18
$298.94K
Lazarus Krikorian
1 Sep 2026
SVP & Chief Accounting Officer
Sold on a plan
985
$325.97
$321.08K
Robert P. Mauch
18 Feb 2026
President & CEO
Sold on a plan
1,333
$359.46
$479.16K
Elizabeth S Campbell
1 Oct 2025
Executive Vice President
Sold on a plan
1,886
$313.28
$590.85K
Elizabeth S Campbell
24 Mar 2025
Executive Vice President
Sold on a plan
2,000
$268.28
$536.56K
Elizabeth S Campbell
24 Mar 2025
Executive Vice President
Sold on a plan
2,127
$268.28
$570.63K
Gina Clark
18 Mar 2024
Executive Vice President
Sold on a plan
9,644
$238.12
$2.30M
Gina Clark
10 Oct 2023
Executive Vice President
Sold on a plan
10,695
$187.00
$2.00M
Robert P. Mauch
25 Sep 2023
Executive Vice President & COO
Sold on a plan
20,197
$185.00
$3.74M
Showing 250 of 403 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 784
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 295
Sales at will 63
Transactions with no price 0
Shares from compensation/vesting 12,885,000
Sales filed before the plan box existed 34
History held since 2 Nov 2006